BUILDING CAR T RESOURCES FOR CLINICAL NURSING...47th Annual Oncology Nursing Society Congress, April 27–May 1, 2022, Anaheim, CA

As the FDA continues to approve commercial Chimeric antigen receptor T (CAR- T) cell treatments, there is a growing need for quick access to resources when providing direct care to patients undergoing treatments. Commercial products require strict oversite by the organization to ensure all FDA-requi...

Descripción completa

Detalles Bibliográficos
Publicado en:Oncology Nursing Forum Vol. 49; no. 2; pp. 9 - 11
Autores principales: Graham, Shawnette, Shuey, Kathleen, De Paula Filho, Italo
Formato: abstract proceedings Journal Article
Publicado: Oncology Nursing Society Mar2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155510816&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 155510816
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0190535X
        4F0
      jtl: Oncology Nursing Forum
      issn: 0190535X
      maglogo: N
    pubinfo:
      dt: Mar2022
      vid: 49
      iid: 2
      pid: 12496
      pub: Oncology Nursing Society
      place: Pittsburgh, Pennsylvania
    artinfo:
      ui:
        155510816
        155510816
        155510816
        10.1188/22.ONF.E1
        155510816
      ppf: 9
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: BUILDING CAR T RESOURCES FOR CLINICAL NURSING...47th Annual Oncology Nursing Society Congress, April 27–May 1, 2022, Anaheim, CA
      aug:
        au:
          Graham, Shawnette
          Shuey, Kathleen
          De Paula Filho, Italo
        affil: Baylor University Medical Center, Dallas, TX
      sug:
        subj:
          Receptors, Cell Surface
          T Lymphocytes
          Congresses and Conferences California
          California
      ab: As the FDA continues to approve commercial Chimeric antigen receptor T (CAR- T) cell treatments, there is a growing need for quick access to resources when providing direct care to patients undergoing treatments. Commercial products require strict oversite by the organization to ensure all FDA-required components are met due to the high risk of patient mortality related to the treatment. Having resources available for bedside nurses to assist in early recognition of cytokine release syndrome and/or immune effector cell-associated neurotoxicity syndrome are vital to patient safety. Currently, our program provides five different commercial products that have slightly different interventions based on patient symptom grading. Bedside nurses are tasked with utilizing our SBAR communication process with the on-call provider to ensure early intervention. To provide nursing immediate access to materials, CAR T resources were placed on Microsoft Teams to allow mobile and remote access. Interventions included creating a Teams channel titled CAR T Binder, creating separate folders for commercially approved products, organizing the folders in a standard manner to ensure quick access to needed documents, and maintaining the resources to ensure accuracy for clinical nurses. In evaluating the process, nurses expressed the ease of finding the information on their personnel phones and increased comfort level with knowledge of where to find immediate access to the information. For staff who do not choose to use their phones, they are able to log in to the Teams site on desktop computers and access the information. The resources they have found the most useful are the admission and prior to infusion check list. They can review their prior education materials before caring for the patient. Due to lack of provider access to Teams, the decision was made to keep a hard-bound binder available on the unit for providers to access the grading and treatment guidelines. The quick access to resources was well received by staff. With the addition of new commercial treatments, new folders and materials will be added. The leadership team continues ongoing conversations regarding the Teams channel and suggestions for additional resources needed. As this field continues to expand to multiple different cancer diagnoses with varying treatment guidelines, it is vital to assist clinical nurses in providing quality patient care and ensuring early recognition for patient safety.
      pubtype: Academic Journal
      doctype:
        abstract
        proceedings
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N